Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Cancer research institute
Jun 21, 2024, 21:22 |
Blog
Kimryn Rathmell: A unique national resource that translates basic science discoveries into novel therapies
Kimryn Rathmell shared on X: "I was delighted to welcome HHS.gov Deputy Secretary Andrea Palm…
Jun 21, 2024, 18:17 |
Cancer Types
Craniopharyngioma in Adults: What patients should know about
Craniopharyngiomas are rare, benign brain tumors that develop near the pituitary gland and hypothalamus, which are critical regions for hormone regulation…
Jun 21, 2024, 17:14 |
Blog
Amalya Sargsyan: Opening a new chapter in clinical trials for LMICs
Amalya Sargsyan shared a post on X: "Opening a new chapter in clinical trials for…
Jun 21, 2024, 16:06 |
Cancer Types
Glioblastoma in Children: What patients and caregivers should know about
What is Glioblastoma? Pediatric glioblastoma is a rare and aggressive brain tumor that primarily affects children. It accounts for approximately 3% of…
Jun 21, 2024, 14:36 |
Insight
High ORR and low CRS rate with Linvoseltamab for R/R Multiple Myeloma
Recently Jeffrey Zonder shared a post on X about a recent paper by Naresh Bumma…
Jun 21, 2024, 13:06 |
Career
Yardena Samuels: An absolute honor to be elected as the next EACR president
Yardena Samuels, Full Professor at Weizmann Institute of Science, posted on LinkedIn: "It is an…
Jun 21, 2024, 12:28 |
Insight
Paolo Tarantino: The CAPItello290 trial did not meet the dual primary endpoints
Paolo Tarantino shared on X/Twitter: "Press Release: the CAPItello290 trial of 1L paclitaxel +/- capivasertib in…
Jun 21, 2024, 11:57 |
Blog
Elad Sharon: Two of my major trials led to FDA Oncology approvals
Elad Sharon, Clinical and Translational Director of Dana-Farber Cancer Institute, shared on X/Twitter: "Past week,…
Jun 21, 2024, 11:16 |
Insight
Paolo Tarantino: Phase 1 trial of the MMAF-based, HER2-targeting ADC FS-1502 published in Nature Communications
Paolo Tarantino shared on X/Twitter: "Phase 1 trial of the MMAF-based, HER2-targeting ADC FS-1502 published…
Jun 21, 2024, 10:25 |
Blog
Mala Shanmugam: A legend has passed...
Mala Shanmugam, Associate Professor in the Department of Hematology and Medical Oncology at the Winship…
183
184
185
186
187
All:
2762
Posts:
1841 - 1850
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Paolo Tarantino: Top 10 Breast Cancer abstracts from ESMO2024
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 2
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube